Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM
No-Receipt date
2021-00567 - 11/02/2021
No-Filing date
20210400390 - 11/02/2021
No-Granting date
3106332 - 19/02/2021
No-EPO application date
14702977.1 - 09/01/2014
No-EPO granting date
2943185 - 18/11/2020
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2021 - 16/03/2021
Expiration date
10/01/2034
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201361750797 P09/01/2013/US
US201361762833 P08/02/2013/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/5513
A61K 9/16
A61K 9/50
A61P 25/22
A61P 25/24
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1301478
EDGEMONT PHARMACEUTICALS, LLC LIQUIDATING TRUST
1037 RAYMONT BLVD., SUITE 1520
NEWARK, NJ
07102
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3224299
SALTEL, DOUGLAS A.
3224300
VACHON, MICHAEL
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
12 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).